CME GROUP INC. (CME) Form 10-Q — Jul 24, 2026
CME Group reported financial results for the second quarter of 2026, with total revenues increasing 1% to $1.7 billion compared to the prior year quarter. Net income rose 2% to $1.0 billion, or $2.88 per diluted share, driven by a 20% increase in market data revenue which offset a 3% decline in clearing and transaction fees due to a lower average rate per contract. For the six months ended June 30, 2026, the company demonstrated stronger growth with total revenues up 8% to $3.6 billion and net income increasing 11% to $2.2 billion.
Key figures
- Eps
- 2.88
- Shares Outstanding
- 359576125
- Share Repurchase Q2 Usd
- 0.7 billion
- Q2 Market Data Revenue Growth
- 20%
- Remaining Repurchase Authorization
- 1.5 billion
Price after filing
Close on the filing date to close N calendar days later (from $255.31). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.